The Blood Collection Devices Market size was estimated at USD 7.63 billion in 2023 and expected to reach USD 8.15 billion in 2024, at a CAGR 7.32% to reach USD 12.52 billion by 2030.
Blood collection devices are specialized instruments used in the medical field to extract human blood for diagnostic purposes, treatment monitoring, blood donations, and research. These devices are designed to assure the safety, accuracy, and efficiency of the blood collection process. Blood collection devices are crucial in minimizing the risk of contamination, assuring the integrity of the blood sample, and reducing discomfort during the collection process. The increasing cases of blood-related disorders and chronic diseases globally drive the demand for blood tests, fueling the market’s growth. In addition, rising healthcare investments from the private & public sectors boost innovation in the market. However, the surging incidence of blood collection device recall impacts the expansion of the market. Furthermore, innovations in blood collection methods and devices offer more efficient, less invasive, and safer options for blood collection, pushing the market forward.
Regional Insights
In the American region, the demand for blood collection devices remains high due to the strong presence of healthcare facilities and a robust regulatory framework ensuring safety and efficacy. Ongoing innovations have focused on enhancing the safety and comfort of blood collection processes. Investments are directed towards automation and integration of digital technologies in collection devices. Customer purchasing behavior emphasizes quality, reliability, and technological advancements. European Union countries have stringent regulations governing medical devices, including blood collection devices. The focus is on safety, precision, and minimizing the invasiveness of blood collection techniques. The European market is distinguished by high demand for devices that are environmentally sustainable and ergonomic. Research and investment in the EU aim to reduce the ecological footprint of disposable devices while maintaining their clinical efficacy. The Middle East has been witnessing substantial growth in the healthcare sector, with significant investments in hospital infrastructure and medical technology. The APAC’s rapidly expanding healthcare sector is propelling the demand for blood collection devices. The countries across the region have implemented significant reforms in healthcare policies, thereby attracting investments in both domestic and international market players. Innovations are particularly focused on disposable and user-friendly devices.
Market Insights
Market Dynamics
The market dynamics represent an ever-changing landscape of the Blood Collection Devices Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
Market Drivers
Rising cases of accidents or trauma cases with need for complex surgeries
Demand for blood components and blood donations
Availability of custom-designed blood collection devices
Market Restraints
Surging incidence of blood collection device recall
Market Opportunities
Advancements in blood collection and sampling technologies
Establishments of new blood testing laboratories worldwide
Market Challenges
Improper design of blood collection devices and inaccuracy of results
Market Segmentation Analysis
Product: Ongoing advancements blood collection systems to facilitate a seamless collection process
Application: Growing awareness about early diagnosis driving the innovations of blood collection devices
Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Blood Collection Devices Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Blood Collection Devices Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Nipro Innovates in Blood Collection with Introduction of a Novel Air-Free Design
Nipro filed a patent for an advanced blood collection device engineered to optimize the sample integrity and user safety during the blood collection process. This innovative instrument distinguishes itself by incorporating a specialized air-free blood collection technology, which essentially involves a uniquely designed, air-tight chamber connected to a member with a hollow needle. This design aims to enhance the quality of blood samples by minimizing exposure to air, which significantly impact the sample's viability for diagnostic purposes.
BD Secures FDA 510(k) Clearance for Innovative Fingertip Blood Collection Device
Becton, Dickinson and Company (BD) announced receiving FDA 510(k) clearance for its fingertip blood collection device to transform the landscape of blood sampling by enhancing the convenience and efficiency of blood collection processes. Specifically designed for a wide array of testing requirements, including infectious disease diagnostics, chronic disease monitoring, and wellness testing, the device is a testament to BD's commitment to improving patient care and outcomes.
BD's Introduction of Needle-Free Device to Enhance Patient Comfort
Becton, Dickinson, and Company (BD) unveiled a needle-free blood collection device to enhance patient comfort by eliminating the need for traditional needle-based blood draws and optimizing the efficiency and safety of the collection process for healthcare professionals. Addressing critical concerns around needle-stick injuries and infection transmission, this device represents a significant leap forward in medical safety protocols.
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Blood Collection Devices Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Blood Collection Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AdvaCare Pharma, Avanos Medical, Inc., Avantor, Inc., B. Braun SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biosigma S.p.A., Cardinal Health, Inc., Exelint International, Co., Fresenius SE & Co. KGaA, Greiner AG, Haemonetics Corporation, ICU Medical, Inc., ITL Health Group, Kawasumi Laboratories America, Inc., Lasany International, Medtronic PLC, Nipro Corporation, Qiagen N.V., Sarstedt AG & Co. KG, Sekisui Medical Co., Ltd., Siemens Healthineers AG, Terumo Corporation, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
This research report categorizes the Blood Collection Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Blood Collection Needles/Holders
Blood Collection System
Blood Collection Tubes
Plasma Blood Tubes
Serum Tubes
Lancet
Method
Automated Blood Collection
Manual Blood Collection
Material
Glass
Plastic
Rubber
Stainless Steel
Application
Diagnostic
Therapeutics
End-user
Blood Donation Centers
Diagnostic & Pathology Laboratory
Hospitals & Clinics
Region
Americas
Argentina
Bolivia
Brazil
Canada
Chile
Colombia
Costa Rica
Dominican Republic
Guatemala
Mexico
Panama
Paraguay
Peru
Puerto Rico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Ecuador
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising cases of accidents or trauma cases with need for complex surgeries
5.1.1.2. Demand for blood components and blood donations
5.1.1.3. Availability of custom-designed blood collection devices
5.1.2. Restraints
5.1.2.1. Surging incidence of blood collection device recall
5.1.3. Opportunities
5.1.3.1. Advancements in blood collection and sampling technologies
5.1.3.2. Establishments of new blood testing laboratories worldwide
5.1.4. Challenges
5.1.4.1. Improper design of blood collection devices and inaccuracy of results
5.2. Market Segmentation Analysis
5.2.1. Product: Ongoing advancements blood collection systems to facilitate a seamless collection process
5.2.2. Application: Growing awareness about early diagnosis driving the innovations of blood collection devices
5.3. Cumulative Impact of High Inflation
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Regulatory Framework Analysis
5.7. Client Customization
6. Blood Collection Devices Market, by Product
6.1. Introduction
6.2. Blood Collection Needles/Holders
6.3. Blood Collection System
6.4. Blood Collection Tubes
6.5. Lancet
7. Blood Collection Devices Market, by Method
7.1. Introduction
7.2. Automated Blood Collection
7.3. Manual Blood Collection
8. Blood Collection Devices Market, by Material
8.1. Introduction
8.2. Glass
8.3. Plastic
8.4. Rubber
8.5. Stainless Steel
9. Blood Collection Devices Market, by Application
9.1. Introduction
9.2. Diagnostic
9.3. Therapeutics
10. Blood Collection Devices Market, by End-user
10.1. Introduction
10.2. Blood Donation Centers
10.3. Diagnostic & Pathology Laboratory
10.4. Hospitals & Clinics
11. Americas Blood Collection Devices Market
11.1. Introduction
11.2. Argentina
11.3. Bolivia
11.4. Brazil
11.5. Canada
11.6. Chile
11.7. Colombia
11.8. Costa Rica
11.9. Dominican Republic
11.10. Guatemala
11.11. Mexico
11.12. Panama
11.13. Paraguay
11.14. Peru
11.15. Puerto Rico
11.16. United States
12. Asia-Pacific Blood Collection Devices Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Blood Collection Devices Market
13.1. Introduction
13.2. Denmark
13.3. Ecuador
13.4. Egypt
13.5. Finland
13.6. France
13.7. Germany
13.8. Israel
13.9. Italy
13.10. Netherlands
13.11. Nigeria
13.12. Norway
13.13. Poland
13.14. Qatar
13.15. Russia
13.16. Saudi Arabia
13.17. South Africa
13.18. Spain
13.19. Sweden
13.20. Switzerland
13.21. Turkey
13.22. United Arab Emirates
13.23. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Nipro Innovates in Blood Collection with Introduction of a Novel Air-Free Design
14.3.2. BD Secures FDA 510(k) Clearance for Innovative Fingertip Blood Collection Device
14.3.3. BD's Introduction of Needle-Free Device to Enhance Patient Comfort
14.3.4. Aptar and Tasso's Alliance to Revolutionize Blood Collection with Digital Integration
14.3.5. FDA Grants Clearance to YourBio Health’s Innovative Blood Collection Device, Enhancing Efficiency and Patient Experience